Ruggero G. Fariello

Mohlin, AG, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Synergistically Acting on Myostatin and Agrin Pathways Increases Neuromuscular Junction Stability and Endurance in Old Mice.

Synergistically Acting on Myostatin and Agrin Pathways Increases Neuromuscular Junction Stability and Endurance in Old Mice.

Journal: Aging and disease

Published: April 08, 2023

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease.

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease.

Journal: NPJ Parkinson's disease

Published: August 18, 2020

A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.

A new protein curbs the hypertrophic effect of myostatin inhibition, adding remarkable endurance to motor performance in mice.

Journal: PloS one

Published: July 26, 2019

Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction.

Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction.

Journal: PloS one

Published: November 04, 2013

Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.

Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.

Journal: The journal of nutrition, health & aging

Published: August 13, 2013

Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain.

Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain.

Journal: Neuropharmacology

Published: June 10, 2013

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.

Journal: Experimental gerontology

Published: January 02, 2012

C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.

C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.

Journal: Experimental gerontology

Published: December 26, 2011

Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).

Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).

Journal: The journal of nutrition, health & aging

Published: December 14, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026